Related Experiment Video
Updated: Aug 9, 2026
08:45
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Echinocandin antifungals: review and update
1Hematology/Oncology and Infectious Disease, Veterans Affairs Medical Center, University of Minnesota, Minneapolis, MN 55417, USA. morri002@umn.edu
Expert Review of Anti-Infective Therapy
|April 7, 2006
Summary
Echinocandins are novel parenteral antifungal agents targeting fungal cell walls. They offer effective treatment options for various fungal infections, including candidemia and aspergillosis.
Area of Science:
- Pharmacology
- Mycology
Background:
- Echinocandins represent a new class of antifungal drugs.
- They function by inhibiting 1,3-beta-glucan synthesis in the fungal cell wall.
- Currently, only parenteral formulations are available.
Purpose of the Study:
- To review the role and applications of echinocandin antifungal agents.
- To highlight approved indications and emerging uses of echinocandins.
- To discuss their significance in treating fungal infections.
Main Methods:
- Review of existing literature on echinocandins.
- Analysis of approved indications for caspofungin, micafungin, and anidulafungin.
- Examination of anecdotal and combination therapy uses.
Main Results:
- Caspofungin, micafungin, and anidulafungin are approved for specific fungal infections like candidiasis and aspergillosis.
- Micafungin is also used for prophylaxis in stem cell transplant recipients.
- These agents show potential in treating less common fungal pathogens and in combination therapies.
Conclusions:
- Echinocandins are a valuable addition to antifungal therapies.
- They are effective against various fungal infections in both immunocompromised and immunocompetent individuals.
- Their role continues to expand in clinical practice.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...